Sulfite Oxidase Deficiency Medication
- Author: Georgianne L Arnold, MD; Chief Editor: Bruce Buehler, MD more...
Medication Summary
Various drug treatments have been attempted. Doses are experimental and are not listed in this article. Attempt drug therapy with the assistance of a metabolic specialist or a neurologist. No drug treatments have proven effective in reversing profound brain damage in individuals with sulfite oxidase deficiency.
Betaine has been used to increase remethylation of homocysteine back to methionine, thus decreasing cysteine and, ultimately, sulfite levels (see the image below).
Sulfite oxidase deficiency and molybdenum cofactor deficiency in the metabolism of sulfated amino acids. High-dose thiamine has been used to replace thiamine destroyed by sulfite.
Cysteamine and penicillamine have been used to chelate sulfite. Cysteamine has been shown to have some biochemical effect; however, no clinical effect has been observed with use of this drug.
Supplementation with sulfate, molybdenum cofactor, tetrahydrobiopterin, and uric acid has been proposed in order to replace body stores. Molybdenum cofactor is not sufficiently stable for administration, and tetrahydrobiopterin supplementation has not been effective. Currently, no reports of effectiveness of sulfate and uric acid administration are available.
Johnson-Winters K, Tollin G, Enemark JH. Elucidating the catalytic mechanism of sulfite oxidizing enzymes using structural, spectroscopic, and kinetic analyses. Biochemistry. Aug 31 2010;49(34):7242-54. [Medline]. [Full Text].
Tan WH, Eichler FS, Hoda S, et al. Isolated sulfite oxidase deficiency: a case report with a novel mutation and review of the literature. Pediatrics. Sep 2005;116(3):757-66. [Medline].
Bindu PS, Christopher R, Mahadevan A, Bharath RD. Clinical and imaging observations in isolated sulfite oxidase deficiency. J Child Neurol. Aug 2011;26(8):1036-40. [Medline].
Hoffmann C, Ben-Zeev B, Anikster Y, et al. Magnetic resonance imaging and magnetic resonance spectroscopy in isolated sulfite oxidase deficiency. J Child Neurol. Oct 2007;22(10):1214-21. [Medline].
Arnold GL, Greene CL, Stout JP, Goodman SI. Molybdenum cofactor deficiency. J Pediatr. Oct 1993;123(4):595-8. [Medline].
Johnson JL. Prenatal diagnosis of molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. Prenat Diagn. Jan 2003;23(1):6-8. [Medline].
Johnson JL, Wadman SK. Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. In: The Metabolic and Molecular Bases of Inherited Disease. 2nd ed. 1995:2271-86.
Kucukatay V, Savcioglu F, Hacioglu G, et al. Effect of sulfite on cognitive functions in normal and sulfite oxidase deficient rats. Neurotoxicol Teratol. 2005;27:47-54. [Medline].
Simmonds HA, Hoffmann GF, Perignon JL, et al. Diagnosis of molybdenum cofactor deficiency. Lancet. Feb 20 1999;353(9153):675. [Medline].
Waring WS, Maxwell S. Diagnosis of molybdenum cofactor deficiency. Lancet. Feb 20 1999;353(9153):675-6. [Medline].

